pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

mavupharma PRESS RELEASE ARCHIVE

Jul 15, 2019

AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma

Jan 3, 2019

Mavupharma Selects First Immuno-Oncology Clinical Candidate MAVU-104, an Oral STING Pathway Enhancer

Nov 29, 2017

Frazier-backed Mavupharma secures $20M in Series A financing to fund STING program

Google Analytics Alternative